SecSonar.com

Journey Medical Corporation (DERM)

Journey Medical Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Journey Medical Corporation (DERM) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $171.5M. Revenue grew 10.2% year-over-year and free cash flow was negative at -$12.4M. This page tracks DERM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 41 employees · IPO Nov 12, 2021

Valuation

Valuation & price

$6.33 · as of May 17, 2026 · -31.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

5.38

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$9.11$6.75$4.39Jul 25Dec 25Jun 26Jul 7, 25$7.11Jul 9, 25$7.14Jul 11, 25$7.15Jul 15, 25$6.98Jul 17, 25$7.30Jul 21, 25$7.19Jul 23, 25$7.39Jul 25, 25$7.59Jul 29, 25$7.59Jul 31, 25$7.35Aug 4, 25$7.14Aug 6, 25$7.23Aug 8, 25$7.57Aug 12, 25$8.54Aug 14, 25$7.26Aug 18, 25$7.00Aug 20, 25$7.07Aug 22, 25$7.47Aug 26, 25$7.42Aug 28, 25$7.27Sep 3, 25$6.95Sep 5, 25$7.01Sep 9, 25$7.45Sep 11, 25$7.35Sep 15, 25$7.12Sep 17, 25$7.05Sep 19, 25$7.30Sep 23, 25$7.51Sep 25, 25$6.90Sep 29, 25$7.10Oct 1, 25$7.25Oct 3, 25$7.33Oct 7, 25$7.55Oct 9, 25$7.55Oct 13, 25$7.00Oct 15, 25$7.51Oct 17, 25$7.20Oct 21, 25$7.35Oct 23, 25$7.50Oct 27, 25$8.02Oct 30, 25$8.31Nov 3, 25$8.52Nov 5, 25$8.84Nov 7, 25$9.11Nov 11, 25$9.05Nov 13, 25$7.69Nov 17, 25$7.69Nov 19, 25$7.65Nov 21, 25$7.46Nov 25, 25$7.86Nov 28, 25$8.07Dec 2, 25$7.41Dec 4, 25$7.81Dec 8, 25$8.20Dec 10, 25$7.70Dec 12, 25$7.67Dec 16, 25$7.88Dec 18, 25$7.92Dec 22, 25$8.01Dec 24, 25$8.13Dec 29, 25$7.71Jan 2, 26$7.45Jan 6, 26$7.22Jan 8, 26$7.31Jan 12, 26$7.74Jan 14, 26$7.84Jan 16, 26$8.01Jan 21, 26$8.87Jan 23, 26$8.68Jan 27, 26$8.72Jan 29, 26$8.45Feb 2, 26$8.59Feb 4, 26$8.42Feb 6, 26$8.35Feb 10, 26$8.10Feb 12, 26$7.71Feb 17, 26$8.10Feb 19, 26$8.46Feb 23, 26$8.55Feb 25, 26$8.73Mar 2, 26$8.09Mar 4, 26$8.04Mar 6, 26$7.77Mar 10, 26$8.15Mar 12, 26$7.76Mar 16, 26$7.45Mar 18, 26$7.12Mar 20, 26$6.63Mar 24, 26$6.91Mar 26, 26$4.78Mar 30, 26$4.39Apr 1, 26$4.64Apr 6, 26$4.86Apr 8, 26$5.33Apr 10, 26$5.17Apr 14, 26$5.26Apr 16, 26$5.17Apr 20, 26$5.19Apr 22, 26$5.04Apr 24, 26$5.15Apr 28, 26$5.26May 1, 26$5.19May 5, 26$5.18May 7, 26$5.00May 11, 26$5.00May 13, 26$5.19May 15, 26$6.33May 19, 26$6.15May 21, 26$6.21May 26, 26$6.12May 28, 26$6.20Jun 1, 26$6.09Jun 3, 26$6.06Jun 5, 26$5.97Jun 9, 26$6.18Jun 11, 26$6.27Jun 15, 26$6.34Jun 17, 26$5.92Jun 22, 26$6.43Jun 26, 26$6.62
$4.3952-week range$9.26
Loading valuation history…

Fundamentals

Key fundamentals

$171.5M

Market cap

10.2%

Revenue growth (YoY)

59.3%

Gross margin

-$12.4M

Free cash flow (USD)

-$24M

Net debt

Net cash position

19.9%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$22.6MFY 2017$4.5MFY 2018$42.3MFY 2019$34.9MFY 2020$44.5MFY 2021$63.1MFY 2022$73.7MFY 2023$79.2MFY 2024$56.1MFY 2025$61.9M
$22.6M$61.9M

Free cash flow by year

2016 → 2025

FY 2016$-74.9MFY 2017$-104.2MFY 2018$-213.7MFY 2019$6.6MFY 2020$3.9MFY 2021$-12.2MFY 2022$-33.5MFY 2023$240.0KFY 2024$-24.1MFY 2025$-12.4M
-$74.9M-$12.4M

Gross margin by year

2021 → 2025

FY 202149.2%FY 202258.2%FY 202366.3%FY 202462.8%FY 202559.3%
49.2%59.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 25, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventPharmacy Benefit ExpansionApr 21, 2026Filing

Questions

Frequently asked questions

What is Journey Medical Corporation's market cap?

Journey Medical Corporation (DERM) has a market capitalization of $171.5M.

What is DERM's P/E ratio?

A meaningful P/E ratio is not available for DERM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is DERM's price-to-book (P/B) ratio?

DERM trades at 5.38 times book value per share.

Are insiders buying DERM stock?

SEC Form 4 filings show no open-market insider buys at Journey Medical Corporation in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

OGI

Organigram Global Inc.

$163.3M

LFCR

Lifecore Biomedical, Inc.

$187.5M

ASRT

Assertio Holdings, Inc.

$151.4M

EMBC

Embecta Corp.

$192.5M

ACB

Aurora Cannabis Inc.

$203.3M

CPIX

Cumberland Pharmaceuticals Inc.

$94.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.